Annual Total Expenses
$134.24 M
+$16.28 M+13.80%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual total expenses is $134.24 million, with the most recent change of +$16.28 million (+13.80%) on December 31, 2022.
- During the last 3 years, JNCE annual total expenses has risen by +$39.19 million (+41.23%).
Performance
JNCE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Expenses
$31.66 M
+$256.00 K+0.82%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly total expenses is $31.66 million, with the most recent change of +$256.00 thousand (+0.82%) on December 31, 2022.
- Over the past year, JNCE quarterly total expenses has increased by +$1.38 million (+4.55%).
Performance
JNCE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
JNCE Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | +4.5% |
| 3 y3 years | +41.2% | +34.5% |
| 5 y5 years | +47.8% | +29.0% |
JNCE Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -12.1% | -15.5% | -4.4% |
| 5 y | 5-year | at high | -29.2% | -15.5% | -25.7% |
| alltime | all time | at high | -87.9% | -15.5% | -68.0% |
Jounce Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $134.24 M(+13.8%) | $31.66 M(+0.8%) |
| Sep 2022 | - | $31.41 M(-6.8%) |
| Jun 2022 | - | $33.71 M(-10.0%) |
| Mar 2022 | - | $37.46 M(+23.7%) |
| Dec 2021 | $117.96 M(+9.8%) | $30.28 M(+0.5%) |
| Sep 2021 | - | $30.14 M(+2.5%) |
| Jun 2021 | - | $29.42 M(+4.6%) |
| Mar 2021 | - | $28.12 M(+4.5%) |
| Dec 2020 | $107.46 M(+13.0%) | $26.92 M(+7.2%) |
| Sep 2020 | - | $25.10 M(-11.1%) |
| Jun 2020 | - | $28.25 M(+3.9%) |
| Mar 2020 | - | $27.18 M(+15.5%) |
| Dec 2019 | $95.06 M | $23.53 M(+9.0%) |
| Sep 2019 | - | $21.60 M(-15.1%) |
| Jun 2019 | - | $25.45 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $24.47 M(+5.3%) |
| Dec 2018 | $96.50 M(+6.2%) | $23.25 M(-0.1%) |
| Sep 2018 | - | $23.27 M(-7.0%) |
| Jun 2018 | - | $25.02 M(+0.2%) |
| Mar 2018 | - | $24.96 M(+1.7%) |
| Dec 2017 | $90.86 M(+75.9%) | $24.54 M(+9.2%) |
| Sep 2017 | - | $22.46 M(-3.7%) |
| Jun 2017 | - | $23.32 M(+13.5%) |
| Mar 2017 | - | $20.54 M(+34.2%) |
| Dec 2016 | $51.66 M(+70.0%) | $15.31 M(+16.9%) |
| Sep 2016 | - | $13.09 M(+5.9%) |
| Jun 2016 | - | $12.36 M(+13.4%) |
| Mar 2016 | - | $10.90 M(+7.5%) |
| Dec 2015 | $30.40 M(+87.5%) | $10.14 M |
| Dec 2014 | $16.21 M | - |
FAQ
- What is Jounce Therapeutics annual total expenses?
- What is the all time high annual total expenses for Jounce Therapeutics?
- What is Jounce Therapeutics annual total expenses year-on-year change?
- What is Jounce Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly total expenses year-on-year change?
What is Jounce Therapeutics annual total expenses?
The current annual total expenses of JNCE is $134.24 M
What is the all time high annual total expenses for Jounce Therapeutics?
Jounce Therapeutics all-time high annual total expenses is $134.24 M
What is Jounce Therapeutics annual total expenses year-on-year change?
Over the past year, JNCE annual total expenses has changed by +$16.28 M (+13.80%)
What is Jounce Therapeutics quarterly total expenses?
The current quarterly total expenses of JNCE is $31.66 M
What is the all time high quarterly total expenses for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly total expenses is $37.46 M
What is Jounce Therapeutics quarterly total expenses year-on-year change?
Over the past year, JNCE quarterly total expenses has changed by +$1.38 M (+4.55%)